SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-008014
Filing Date
2019-03-15
Accepted
2019-03-15 19:50:19
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4274
  Complete submission text file 0000899243-19-008014.txt   6266
Mailing Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200
Business Address SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 8200 411724 59 59
BB BIOTECH AG (Reporting) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 19686478

Mailing Address ARA HILL TOP BUILDING, UNIT A-5 PLETTERIJWEG OOST 1, CURACAO WILLEMSTAD P8 000000
Business Address
BIOTECH TARGET N V (Reporting) CIK: 0001259870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 19686477

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1